| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
|
Niyoteka, Stephane
|
|
|
50 |
Suppl 1 |
p. 4010-4023
|
artikel
|
| 2 |
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [18F]FDG PET/CT
|
Nikulin, Pavel
|
|
|
50 |
Suppl 1 |
p. 2751-2766
|
artikel
|
| 3 |
A cycle-consistent adversarial network for brain PET partial volume correction without prior anatomical information
|
Sanaat, Amirhossein
|
|
|
50 |
Suppl 1 |
p. 1881-1896
|
artikel
|
| 4 |
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
|
Guido, Alessandra
|
|
|
50 |
Suppl 1 |
p. 572-580
|
artikel
|
| 5 |
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
|
Darcourt, Jacques
|
|
|
50 |
Suppl 1 |
p. 2727-2735
|
artikel
|
| 6 |
Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer
|
Herold, Alexander
|
|
|
50 |
Suppl 1 |
p. 205-217
|
artikel
|
| 7 |
A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions
|
Cohen, Dan
|
|
|
50 |
Suppl 1 |
p. 1423-1433
|
artikel
|
| 8 |
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support
|
de A. Fernandes, Fernando
|
|
|
50 |
Suppl 1 |
p. 3022-3033
|
artikel
|
| 9 |
A multi-label CNN model for the automatic detection and segmentation of gliomas using [18F]FET PET imaging
|
Rahimpour, Masoomeh
|
|
|
50 |
Suppl 1 |
p. 2441-2452
|
artikel
|
| 10 |
An exploration of the feasibility and clinical value of half-dose 5-h total-body 18F-FDG PET/CT scan in patients with Takayasu arteritis
|
Adili, Dilibire
|
|
|
50 |
Suppl 1 |
p. 2375-2385
|
artikel
|
| 11 |
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma
|
Sachpekidis, Christos
|
|
|
50 |
Suppl 1 |
p. 3697-3708
|
artikel
|
| 12 |
Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma
|
Sachpekidis, Christos
|
|
|
50 |
Suppl 1 |
p. 1158-1167
|
artikel
|
| 13 |
Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody
|
Stergiou, N.
|
|
|
50 |
Suppl 1 |
p. 1306-1317
|
artikel
|
| 14 |
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
|
Wang, Guochang
|
|
|
50 |
Suppl 1 |
p. 3126-3136
|
artikel
|
| 15 |
A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy
|
Yang, Tianhong
|
|
|
50 |
Suppl 1 |
p. 2331-2341
|
artikel
|
| 16 |
Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players
|
Alosco, Michael L.
|
|
|
50 |
Suppl 1 |
p. 435-452
|
artikel
|
| 17 |
Benefit of [18F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma
|
OuYang, Pu-Yun
|
|
|
50 |
Suppl 1 |
p. 881-891
|
artikel
|
| 18 |
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
|
Delker, Astrid
|
|
|
50 |
Suppl 1 |
p. 1280-1290
|
artikel
|
| 19 |
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin
|
Delva, Aline
|
|
|
50 |
Suppl 1 |
p. 48-60
|
artikel
|
| 20 |
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study
|
Long, Yali
|
|
|
50 |
Suppl 1 |
p. 3072-3083
|
artikel
|
| 21 |
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals
|
Ebenau, Jarith L.
|
|
|
50 |
Suppl 1 |
p. 410-422
|
artikel
|
| 22 |
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis
|
Wang, Jingguo
|
|
|
50 |
Suppl 1 |
p. 2394-2408
|
artikel
|
| 23 |
Chlorin e6-loaded goat milk-derived extracellular vesicles for Cerenkov luminescence-induced photodynamic therapy
|
Guo, Rong
|
|
|
50 |
Suppl 1 |
p. 508-524
|
artikel
|
| 24 |
Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
|
Jinghua, Li
|
|
|
50 |
Suppl 1 |
p. 2152-2166
|
artikel
|
| 25 |
Commentary to “[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn’s disease intestinal lesions” by Chen and colleagues
|
Lovinfosse, Pierre
|
|
|
50 |
Suppl 1 |
p. 1278-1279
|
artikel
|
| 26 |
Comparison of [18F]-OC PET/CT and contrast-enhanced CT/MRI in the detection and evaluation of neuroendocrine neoplasms
|
Chen, Donghe
|
|
|
50 |
Suppl 1 |
p. 2420-2431
|
artikel
|
| 27 |
Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head
|
Ooms, Mark
|
|
|
50 |
Suppl 1 |
p. 870-880
|
artikel
|
| 28 |
Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients
|
Liu, Jiayue
|
|
|
50 |
Suppl 1 |
p. 2775-2786
|
artikel
|
| 29 |
Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective
|
Vreeburg, Manon T. A.
|
|
|
50 |
Suppl 1 |
p. 2282-2291
|
artikel
|
| 30 |
Comparison of whole-body DW-MRI with 2-[18F]FDG PET for staging and treatment monitoring of children with Langerhans cell histiocytosis
|
Baratto, Lucia
|
|
|
50 |
Suppl 1 |
p. 1689-1698
|
artikel
|
| 31 |
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
|
Collado Camps, Estel
|
|
|
50 |
Suppl 1 |
p. 996-1004
|
artikel
|
| 32 |
Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics
|
Lucaroni, Laura
|
|
|
50 |
Suppl 1 |
p. 957-961
|
artikel
|
| 33 |
Deep learning-based diagnosis of disease activity in patients with Graves’ orbitopathy using orbital SPECT/CT
|
Yao, Ni
|
|
|
50 |
Suppl 1 |
p. 3666-3674
|
artikel
|
| 34 |
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study
|
Gregory, Jules
|
|
|
50 |
Suppl 1 |
p. 921-928
|
artikel
|
| 35 |
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06
|
Barry, Nathaniel
|
|
|
50 |
Suppl 1 |
p. 3970-3981
|
artikel
|
| 36 |
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
|
Rosar, Florian
|
|
|
50 |
Suppl 1 |
p. 2899-2909
|
artikel
|
| 37 |
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
|
Muehlematter, Urs J.
|
|
|
50 |
Suppl 1 |
p. 3137-3146
|
artikel
|
| 38 |
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study
|
Bottoni, Gianluca
|
|
|
50 |
Suppl 1 |
p. 2477-2485
|
artikel
|
| 39 |
Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure
|
Wang, Yiqun
|
|
|
50 |
Suppl 1 |
p. 1919-1928
|
artikel
|
| 40 |
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
|
Lanfranchi, Francesco
|
|
|
50 |
Suppl 1 |
p. 1090-1102
|
artikel
|
| 41 |
Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
|
Cytawa, Wojciech
|
|
|
50 |
Suppl 1 |
p. 3765-3776
|
artikel
|
| 42 |
Early detection of radiation-induced myocardial damage by [18F]AlF-NOTA-FAPI-04 PET/CT imaging
|
Wei, Yuchun
|
|
|
50 |
Suppl 1 |
p. 453-464
|
artikel
|
| 43 |
EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer
|
Li, Ruping
|
|
|
50 |
Suppl 1 |
p. 2100-2113
|
artikel
|
| 44 |
Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
|
Minczeles, Noémie S.
|
|
|
50 |
Suppl 1 |
p. 1195-1204
|
artikel
|
| 45 |
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
|
Mitjavila, Mercedes
|
|
|
50 |
Suppl 1 |
p. 2486-2500
|
artikel
|
| 46 |
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
|
Jiang, Chunjuan
|
|
|
50 |
Suppl 1 |
p. 275-286
|
artikel
|
| 47 |
Error mitigation enables PET radiomic cancer characterization on quantum computers
|
Moradi, S.
|
|
|
50 |
Suppl 1 |
p. 3826-3837
|
artikel
|
| 48 |
Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors
|
Yamazaki, Kana
|
|
|
50 |
Suppl 1 |
p. 581-592
|
artikel
|
| 49 |
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
|
Geist, Barbara Katharina
|
|
|
50 |
Suppl 1 |
p. 3034-3041
|
artikel
|
| 50 |
Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
|
Mader, Nicolai
|
|
|
50 |
Suppl 1 |
p. 1811-1821
|
artikel
|
| 51 |
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
|
Zhu, Ziyuan
|
|
|
50 |
Suppl 1 |
p. 3425-3438
|
artikel
|
| 52 |
FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use
|
Kirienko, Margarita
|
|
|
50 |
Suppl 1 |
p. 3042-3049
|
artikel
|
| 53 |
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
|
Oprea-Lager, Daniela-Elena
|
|
|
50 |
Suppl 1 |
p. 3439-3451
|
artikel
|
| 54 |
[18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function
|
Peyronneau, MA
|
|
|
50 |
Suppl 1 |
p. 3251-3264
|
artikel
|
| 55 |
Feasibility of acquisitions using total-body PET/CT with a half-dose [68Ga]Ga-FAPI-04 activity in oncology patients
|
Chen, Zijun
|
|
|
50 |
Suppl 1 |
p. 3961-3969
|
artikel
|
| 56 |
[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT
|
Mu, Xingyu
|
|
|
50 |
Suppl 1 |
p. 1205-1215
|
artikel
|
| 57 |
[18F]FAPI PET/CT in the evaluation of focal liver lesions with [18F]FDG non-avidity
|
Zhang, Jing
|
|
|
50 |
Suppl 1 |
p. 937-950
|
artikel
|
| 58 |
[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans
|
Courault, Pierre
|
|
|
50 |
Suppl 1 |
p. 1651-1664
|
artikel
|
| 59 |
[18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects
|
Peng, Liling
|
|
|
50 |
Suppl 1 |
p. 3723-3734
|
artikel
|
| 60 |
[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network
|
Rozenblum, Laura
|
|
|
50 |
Suppl 1 |
p. 3684-3696
|
artikel
|
| 61 |
[18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
|
Kertels, Olivia
|
|
|
50 |
Suppl 1 |
p. 1699-1708
|
artikel
|
| 62 |
[18F]Fluoropivalate, mitochondria, and the resurrection of short-chain fatty acids
|
Filippi, Luca
|
|
|
50 |
Suppl 1 |
p. 3802-3805
|
artikel
|
| 63 |
[18F]FNDP PET neuroimaging test–retest repeatability and whole-body dosimetry in humans
|
Du, Yong
|
|
|
50 |
Suppl 1 |
p. 3659-3665
|
artikel
|
| 64 |
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
|
Zboralski, Dirk
|
|
|
50 |
Suppl 1 |
p. 2621-2635
|
artikel
|
| 65 |
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection
|
Wang, Shujing
|
|
|
50 |
Suppl 1 |
p. 2802-2817
|
artikel
|
| 66 |
First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours
|
Silins, Isabella
|
|
|
50 |
Suppl 1 |
p. 398-409
|
artikel
|
| 67 |
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
|
Samim, Atia
|
|
|
50 |
Suppl 1 |
p. 1146-1157
|
artikel
|
| 68 |
[18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma
|
Wang, Peipei
|
|
|
50 |
Suppl 1 |
p. 3097-3106
|
artikel
|
| 69 |
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients
|
Pauwels, Elin
|
|
|
50 |
Suppl 1 |
p. 1134-1145
|
artikel
|
| 70 |
18F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients
|
de Jongh, Jerney
|
|
|
50 |
Suppl 1 |
p. 756-764
|
artikel
|
| 71 |
Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images
|
Kendrick, Jake
|
|
|
50 |
Suppl 1 |
p. 67-79
|
artikel
|
| 72 |
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization
|
Heid, Irina
|
|
|
50 |
Suppl 1 |
p. 115-129
|
artikel
|
| 73 |
[68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling
|
Zhang, Min
|
|
|
50 |
Suppl 1 |
p. 839-848
|
artikel
|
| 74 |
[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques
|
Watts, Ankit
|
|
|
50 |
Suppl 1 |
p. 1216-1227
|
artikel
|
| 75 |
Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer
|
Lindemann, Marcel
|
|
|
50 |
Suppl 1 |
p. 1183-1194
|
artikel
|
| 76 |
Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer
|
Liu, Shuai
|
|
|
50 |
Suppl 1 |
p. 1521-1531
|
artikel
|
| 77 |
Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study
|
Wang, Guochang
|
|
|
50 |
Suppl 1 |
p. 1499-1509
|
artikel
|
| 78 |
Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma
|
Souza, Stephan P. M.
|
|
|
50 |
Suppl 1 |
p. 2432-2440
|
artikel
|
| 79 |
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study
|
Ke, Zhi-Bin
|
|
|
50 |
Suppl 1 |
p. 1240-1251
|
artikel
|
| 80 |
High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers
|
Qin, Xue
|
|
|
50 |
Suppl 1 |
p. 302-313
|
artikel
|
| 81 |
Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP
|
Brugarolas, Pedro
|
|
|
50 |
Suppl 1 |
p. 344-351
|
artikel
|
| 82 |
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy
|
Banerjee, Rahul
|
|
|
50 |
Suppl 1 |
p. 3349-3353
|
artikel
|
| 83 |
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
|
Derks, Yvonne H. W.
|
|
|
50 |
Suppl 1 |
p. 2872-2884
|
artikel
|
| 84 |
Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside
|
Li, Liqiang
|
|
|
50 |
Suppl 1 |
p. 3735-3749
|
artikel
|
| 85 |
Incremental prognostic value of stress phase entropy over standard PET myocardial perfusion imaging variables
|
Kuronuma, Keiichiro
|
|
|
50 |
Suppl 1 |
p. 3619-3629
|
artikel
|
| 86 |
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys
|
Aweda, Tolulope A.
|
|
|
50 |
Suppl 1 |
p. 667-678
|
artikel
|
| 87 |
In vivo methods for imaging blood–brain barrier function and dysfunction
|
Harris, William James
|
|
|
50 |
Suppl 1 |
p. 1051-1083
|
artikel
|
| 88 |
Long-term impact of myocardial inflammation on quantitative myocardial perfusion—a descriptive PET/MR myocarditis study
|
Buechel, Ronny R.
|
|
|
50 |
Suppl 1 |
p. 3609-3618
|
artikel
|
| 89 |
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study
|
Ballal, Sanjana
|
|
|
50 |
Suppl 1 |
p. 3777-3789
|
artikel
|
| 90 |
Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models
|
Wang, Yan-Ran (Joyce)
|
|
|
50 |
Suppl 1 |
p. 1337-1350
|
artikel
|
| 91 |
Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
|
Arnfield, Evyn G.
|
|
|
50 |
Suppl 1 |
p. 8-9
|
artikel
|
| 92 |
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models
|
Boeke, Simon
|
|
|
50 |
Suppl 1 |
p. 3084-3096
|
artikel
|
| 93 |
Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts
|
Grahovac, M.
|
|
|
50 |
Suppl 1 |
p. 1607-1620
|
artikel
|
| 94 |
Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma
|
Zhang, Xiao
|
|
|
50 |
Suppl 1 |
p. 3062-3071
|
artikel
|
| 95 |
Metformin confers longitudinal cardiac protection by preserving mitochondrial homeostasis following myocardial ischemia/reperfusion injury
|
Tian, Jing
|
|
|
50 |
Suppl 1 |
p. 825-838
|
artikel
|
| 96 |
Minutes to hours after a nuclear event: available radiation poisoning antidotes and practical considerations on possible urgent approaches
|
Taci, Xhoajda
|
|
|
50 |
Suppl 1 |
p. 3498-3505
|
artikel
|
| 97 |
Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images
|
Miller, Robert J. H.
|
|
|
50 |
Suppl 1 |
p. 387-397
|
artikel
|
| 98 |
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET
|
Duan, Heying
|
|
|
50 |
Suppl 1 |
p. 4087-4095
|
artikel
|
| 99 |
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
|
Kosmala, Aleksander
|
|
|
50 |
Suppl 1 |
p. 3011-3021
|
artikel
|
| 100 |
99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types
|
Altunay, Betül
|
|
|
50 |
Suppl 1 |
p. 1005-1013
|
artikel
|
| 101 |
[99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
|
Konrad, Matthias
|
|
|
50 |
Suppl 1 |
p. 3937-3948
|
artikel
|
| 102 |
99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel
|
Rovera, Guido
|
|
|
50 |
Suppl 1 |
p. 3375-3389
|
artikel
|
| 103 |
Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer
|
Lucia, François
|
|
|
50 |
Suppl 1 |
p. 2514-2528
|
artikel
|
| 104 |
New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue
|
Li, Changjian
|
|
|
50 |
Suppl 1 |
p. 494-507
|
artikel
|
| 105 |
New thresholds in semi-quantitative [18F]FDG PET/CT are needed to assess large vessel vasculitis with long-axial field-of-view scanners
|
Knappe, Luisa
|
|
|
50 |
Suppl 1 |
p. 3890-3896
|
artikel
|
| 106 |
Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
|
Unterrainer, Marcus
|
|
|
50 |
Suppl 1 |
p. 3390-3399
|
artikel
|
| 107 |
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
|
Schiebler, Tassilo
|
|
|
50 |
Suppl 1 |
p. 3302-3312
|
artikel
|
| 108 |
Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies
|
van der Weijden, Chris W. J.
|
|
|
50 |
Suppl 1 |
p. 1636-1650
|
artikel
|
| 109 |
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
|
Taprogge, Jan
|
|
|
50 |
Suppl 1 |
p. 3225-3234
|
artikel
|
| 110 |
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial
|
Kitajima, Kazuhiro
|
|
|
50 |
Suppl 1 |
p. 1487-1498
|
artikel
|
| 111 |
Nuclear imaging and therapy in oncology in Poland in 2021–2022
|
Kunikowska, Jolanta
|
|
|
50 |
Suppl 1 |
p. 2236-2239
|
artikel
|
| 112 |
Occipital hypometabolism is a risk factor for conversion to Parkinson’s disease in isolated REM sleep behaviour disorder
|
Carli, Giulia
|
|
|
50 |
Suppl 1 |
p. 3290-3301
|
artikel
|
| 113 |
Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT
|
van Sluis, Joyce
|
|
|
50 |
Suppl 1 |
p. 2258-2270
|
artikel
|
| 114 |
Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy
|
Liu, Yu
|
|
|
50 |
Suppl 1 |
p. 2636-2646
|
artikel
|
| 115 |
Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients
|
Wang, DaQuan
|
|
|
50 |
Suppl 1 |
p. 3400-3413
|
artikel
|
| 116 |
PET/CT scan without sedation: how to use total-body PET/CT to salvage child’s involuntary movement?
|
Li, Yongjiang
|
|
|
50 |
Suppl 1 |
p. 2912-2913
|
artikel
|
| 117 |
PET imaging of PARP expression using 68Ga-labelled inhibitors
|
Wang, Xiangwei
|
|
|
50 |
Suppl 1 |
p. 2606-2620
|
artikel
|
| 118 |
Phantom-based evaluation of yttrium-90 datasets using biograph vision quadra
|
Zeimpekis, Konstantinos G.
|
|
|
50 |
Suppl 1 |
p. 1168-1182
|
artikel
|
| 119 |
Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide–based 18F-FP-R01-MG-F2
|
Nakamoto, Ryusuke
|
|
|
50 |
Suppl 1 |
p. 184-193
|
artikel
|
| 120 |
Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy
|
Xing, Xiaoqing
|
|
|
50 |
Suppl 1 |
p. 1671-1688
|
artikel
|
| 121 |
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma
|
Zhu, Wenjia
|
|
|
50 |
Suppl 1 |
p. 3116-3125
|
artikel
|
| 122 |
Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
|
Ogasawara, Annie
|
|
|
50 |
Suppl 1 |
p. 287-301
|
artikel
|
| 123 |
Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging
|
Ma, Xiaopan
|
|
|
50 |
Suppl 1 |
p. 3838-3850
|
artikel
|
| 124 |
Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primates
|
Chen, Baosheng
|
|
|
50 |
Suppl 1 |
p. 2081-2099
|
artikel
|
| 125 |
Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
|
Ayati, Narjess
|
|
|
50 |
Suppl 1 |
p. 2715-2726
|
artikel
|
| 126 |
Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR
|
Abadie, Bryan
|
|
|
50 |
Suppl 1 |
p. 3910-3916
|
artikel
|
| 127 |
Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images
|
Kendrick, Jake
|
|
|
50 |
Suppl 1 |
p. 4077-4086
|
artikel
|
| 128 |
Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma
|
Zhao, Liang
|
|
|
50 |
Suppl 1 |
p. 593-601
|
artikel
|
| 129 |
Prognostic value of imaging-based ATN profiles in a memory clinic cohort
|
Peretti, Débora E.
|
|
|
50 |
Suppl 1 |
p. 3313-3323
|
artikel
|
| 130 |
Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis
|
Assante, Roberta
|
|
|
50 |
Suppl 1 |
p. 3647-3658
|
artikel
|
| 131 |
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy
|
Winkelmann, Michael
|
|
|
50 |
Suppl 1 |
p. 1406-1413
|
artikel
|
| 132 |
Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging–guided lung cancer resections
|
Azari, Feredun
|
|
|
50 |
Suppl 1 |
p. 2453-2465
|
artikel
|
| 133 |
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
|
Solomonidou, Nantia
|
|
|
50 |
Suppl 1 |
p. 2529-2536
|
artikel
|
| 134 |
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
|
Mossel, Pascalle
|
|
|
50 |
Suppl 1 |
p. 3917-3927
|
artikel
|
| 135 |
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
|
Zwezerijnen, Gerben J. C.
|
|
|
50 |
Suppl 1 |
p. 486-493
|
artikel
|
| 136 |
Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy
|
Peng, Zhengyao
|
|
|
50 |
Suppl 1 |
p. 1291-1305
|
artikel
|
| 137 |
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors
|
Mapelli, Paola
|
|
|
50 |
Suppl 1 |
p. 2818-2829
|
artikel
|
| 138 |
SPECT and CT misregistration reduction in [99mTc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning
|
Lu, Zhonglin
|
|
|
50 |
Suppl 1 |
p. 2319-2330
|
artikel
|
| 139 |
SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021
|
Lindner, O.
|
|
|
50 |
Suppl 1 |
p. 3602-3608
|
artikel
|
| 140 |
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting
|
Song, Hong
|
|
|
50 |
Suppl 1 |
p. 2250-2257
|
artikel
|
| 141 |
Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT
|
Korsholm, Kirsten
|
|
|
50 |
Suppl 1 |
p. 1534-1535
|
artikel
|
| 142 |
Standing on the shoulders of giants: 50 years of EJNM and EJNMMI
|
Carrió, Ignasi
|
|
|
50 |
Suppl 1 |
p. 3489-3493
|
artikel
|
| 143 |
Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumours
|
Shen, Xiuling
|
|
|
50 |
Suppl 1 |
p. 3414-3424
|
artikel
|
| 144 |
SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
|
Hartrampf, Philipp E.
|
|
|
50 |
Suppl 1 |
p. 3465-3474
|
artikel
|
| 145 |
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
|
Watabe, Tadashi
|
|
|
50 |
Suppl 1 |
p. 849-858
|
artikel
|
| 146 |
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study
|
Visser, Denise
|
|
|
50 |
Suppl 1 |
p. 2409-2419
|
artikel
|
| 147 |
The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG
|
Shu, Qiaoqiao
|
|
|
50 |
Suppl 1 |
p. 1442-1452
|
artikel
|
| 148 |
The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE
|
Veerman, Chayenne H. A. M.
|
|
|
50 |
Suppl 1 |
p. 1434-1441
|
artikel
|
| 149 |
The feasibility of ultra-early and fast total‑body [68 Ga]Ga-FAPI-04 PET/CT scan
|
Chen, Ruohua
|
|
|
50 |
Suppl 1 |
p. 661-666
|
artikel
|
| 150 |
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
|
Spohn, Simon K. B.
|
|
|
50 |
Suppl 1 |
p. 218-227
|
artikel
|
| 151 |
The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study
|
Zhang, Han
|
|
|
50 |
Suppl 1 |
p. 1940-1953
|
artikel
|
| 152 |
Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models
|
Li, Cuicui
|
|
|
50 |
Suppl 1 |
p. 168-183
|
artikel
|
| 153 |
The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)
|
Alipour, R.
|
|
|
50 |
Suppl 1 |
p. 2997-3010
|
artikel
|
| 154 |
The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
|
Basso Dias, Adriano
|
|
|
50 |
Suppl 1 |
p. 2167-2176
|
artikel
|
| 155 |
The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience
|
Jia, Xi
|
|
|
50 |
Suppl 1 |
p. 1228-1239
|
artikel
|
| 156 |
The role of quantitative tumor burden based on [68 Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis
|
Chen, Luohai
|
|
|
50 |
Suppl 1 |
p. 525-534
|
artikel
|
| 157 |
The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy
|
Onal, Cem
|
|
|
50 |
Suppl 1 |
p. 3755-3764
|
artikel
|
| 158 |
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
|
Mauguen, Audrey
|
|
|
50 |
Suppl 1 |
p. 2971-2983
|
artikel
|
| 159 |
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients
|
Martini, Anna Lisa
|
|
|
50 |
Suppl 1 |
p. 90-102
|
artikel
|
| 160 |
Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography
|
Noltes, Milou E.
|
|
|
50 |
Suppl 1 |
p. 2736-2750
|
artikel
|
| 161 |
Transfer learning-based attenuation correction for static and dynamic cardiac PET using a generative adversarial network
|
Sun, Hao
|
|
|
50 |
Suppl 1 |
p. 3630-3646
|
artikel
|
| 162 |
TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
|
Quach, Stefanie
|
|
|
50 |
Suppl 1 |
p. 859-869
|
artikel
|
| 163 |
Tumor lesion detection in patients with cervical cancer by indocyanine green near-infrared imaging
|
Li, Pengfei
|
|
|
50 |
Suppl 1 |
p. 1252-1261
|
artikel
|
| 164 |
Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04
|
Chen, Ruohua
|
|
|
50 |
Suppl 1 |
p. 929-936
|
artikel
|
| 165 |
Unmasking disseminated streptococcal infection: role of FDG PET/CT in diagnosis and assessing response to antibiotic treatment
|
Suthar, Ritesh Ramesh
|
|
|
50 |
Suppl 1 |
p. 962-963
|
artikel
|
| 166 |
Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging
|
Williams, Michelle C.
|
|
|
50 |
Suppl 1 |
p. 2656-2668
|
artikel
|
| 167 |
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
|
Jovalekic, Aleksandar
|
|
|
50 |
Suppl 1 |
p. 3276-3289
|
artikel
|
| 168 |
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake
|
Wijngaarden, Jessica E.
|
|
|
50 |
Suppl 1 |
p. 1897-1905
|
artikel
|
| 169 |
Variability of [18F]FDG-PET/LDCT reporting in vascular graft and endograft infection
|
Liesker, David J.
|
|
|
50 |
Suppl 1 |
p. 3880-3889
|
artikel
|
| 170 |
Walk-through flat panel total-body PET: a patient-centered design for high throughput imaging at lower cost using DOI-capable high-resolution monolithic detectors
|
Vandenberghe, Stefaan
|
|
|
50 |
Suppl 1 |
p. 3558-3571
|
artikel
|
| 171 |
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
|
Adams, H.
|
|
|
50 |
Suppl 1 |
p. 1929-1939
|
artikel
|
| 172 |
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC
|
Miedema, Iris H.C.
|
|
|
50 |
Suppl 1 |
p. 2068-2080
|
artikel
|
Tijdschrift beschrijving